Koren Pharmaceutical executives listed just five days the public collective salary increase up to 52%

Up 52% of the overall executive compensation, director general pay increases of 17%! Listed just 5, Koren Pharmaceutical (002422, closing price 93.28 yuan) will be held in the Board considered the company's directors and executives by adjusting the remuneration of the two motions. Pay adjustment so quickly, inIPOIn the first case! Deputy annual salary will be doubled Just Hikvision (002 415, close 81.20 yuan) has just issued a red envelope and the introduction of 250 million yuan profit-sharing plan for 49 executives reap 34 million yuan, the Cologne medicine yesterday also generous for the company Public executives prepared a great surprise. However, with Hikvision difference is that Cologne is the core of Pharmaceutical personnel salary increases. Koren medicine yesterday (June 9) Philadelphia Eagles jerseys announced that its Board of Directors passed the "directors remuneration on the adjustment of the motion" and "On the adjustment of the remuneration of senior management of the motion," the two programs. Under the adjustment program, the company chairman Liu innovative, independent director Zhang Qiang, Liu Hong and Roberts Bank's overall pay raise of about 17%. Among them, Liu innovation will pay in 2010 to 120 million, compared to 1.0543 million yuan in 2009 increased by 13.94 percent, the smallest rise; and Zhang Qiang and the others than the annual salary of 60,000 yuan in 2009 increased by 2 million 2010 will be increased to 80,000 yuan. Compared chairman, independent director less than 20% pay raise, the CEO's pay increases in magnitude is quite substantial. Program display, including the Hui Pan, Cheng Zhipeng so the overall pay increase 9 to 52%. Among them, the company's deputy general manager, core technical staff were friendly pay GE the largest growth in its pay 600,000 yuan in 2010 compared with 256,200 yuan in 2009 increased by 134.19%! Information, Ge You are a former director of Shanghai Yanan pharmaceutical factory, Shanghai Heng Shou Tang Pharmaceutical Co., Ltd. and vice president of production technology, Asia Pacific, Germany, ratiopharm pharmaceutical quality manager positions, from June 2007 onwards Renke Lun medicine Trade Quality Director, in June 2009 was promoted to Deputy General Manager and is responsible for quality supervision and management. Although a higher position in the company, but were friends in 2009 GE annual salary was lower, less than 30 million, after the San Diego Chargers jerseys pay raise, his salary and other executives will be very. The overall level of operator on the middle sector The reason for the pay raise, Koren medicine that since the company in 2007 and 2009 operating income CAGR of 33% net profit CAGR over the past three years, 51%; the company's directors and senior management remuneration has not been a big adjustment, so the actual situation according to the company and in the light industry pay scale similar to the level of listed companies, decided to pay the company to adjust the relevant personnel. "Daily Economic News" reporter learned that, as of yesterday's close, the total pharmaceutical market value of Cologne has reached 22.387 billion yuan, higher than its competitorsDouble-Crane Pharmaceutical5.943 billion yuan, in the biopharmaceutical segment ranked 11th, higher than the total market value of the company, only Haipu Rui, Shanghai Pharmaceutical,Hengrui MedicineAnd others. By comparison, the reporter found, Koren medicine last year, the annual salary of executives and directors under the middle level in the industry. Although the company issued 5.627 million yuan last year, total remuneration of executives and directors, much higher thanHarbin women nfl jerseys Pharmaceutical Share, Hai Purui,East E-JiaoCompanies, but production of a large infusion of Double-Crane Pharmaceutical products than pharmaceutical executives and directors of Cologne pay remains low. Double-Crane Pharmaceutical in 2009 paid a total remuneration for senior staff 14.1317 million yuan, of which seven executives pay more than 1 million, the company secretaries to directorate, Vice President Zhu Dacheng topped with 1.4803 million yuan, including the other six, vice president of extended The salary also have 130 million. A pharmaceutical industry analyst on condition of anonymity told the "Daily Economic News" reporter, "Koren medicine in recent years, rapid business growth, the increase executive pay, executives will serve on the incentive, which is conducive to the company's long-term development. Also, from increased pay situation, Koren Pharmaceutical executives and directors in 2010 will total more than 7 million yuan compensation, and executives more than 600,000 yuan per capita annual income is also in the whole biological system drug industry has counted on the middle level of the. "(per by journalists)